Developing new drugs to treat cancer involves rigorous research, development, and approval processes. Pre-clinical research occurs in a laboratory setting involving model systems such as animals or cells. Promising results from pre-clinical research led to clinical trials where the drug is tested in patients or healthy volunteers. Once a drug is approved for use in patients, it is continued to be monitored and researched as use increases.